Unresectable HCC patients disposal in the new era of immunotherapy from the elitor study based on the French chief cohort

0 avis

Unresectable HCC patients disposal in the new era of immunotherapy from the elitor study based on the French chief cohort

Archive ouverte

Edité par CCSD ; Wiley-Blackwell -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Unresectable hepatocellular carcinoma at dawn of immunotherapy era: real-world data from the French prospective CHIEF cohort

Archive ouverte | Nguyen-Khac, Eric | CCSD

International audience. Background and objectives Hepatocellular carcinoma epidemiological data are limited in France. The Epidemio Liver Immunotherapy Tecentriq outcome research (ELITor) retrospective study, based ...

THU-466 Treatment with Atezolizumab-Bevacizumab for hepatocellular carcinoma in the French population outside clinical trials: data from the prospective CHIEF cohort

Archive ouverte | Allaire, Manon | CCSD

International audience

ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts

Archive ouverte | Ollivier-Hourmand, Isabelle | CCSD

International audience. Background and aims: Non-O blood group promotes deep vein thrombosis and liver fibrosis in both general population and hepatitis C. We aimed to evaluate the influence of Non-O group on the ou...

Chargement des enrichissements...